Aditya Birla Sun Life Large & Mid Cap Fund Regular-Growth
The fund is rated 0.5 stars. Balance between returns and downside risk provided some support. Investment selection within each asset type and investment selection within each industry were the main limitations and did not provide enough support for a higher rating. Higher annual fee of 2.01% was a minor drawback.
This fund has a bad track record with Asset Selection/Timing, a bad track record with Stock Selection/Timing, a ok risk-reward ratio. It is important to note, however, that this fund has a 5997.921 AUM and a 2.01 expense ratio. Considering all these factors, we have rated this fund as 0.5 star.
எங்கள் score நீண்டகால performance, risk மற்றும் consistency-ஐ மதிப்பிடுகிறது — past returns மட்டும் அல்ல.
Returns
8 Oct 2026 நிலவரப்படி
Risk ratios
30 Sep 2026 நிலவரப்படி
Portfolio
30 Sep 2026 நிலவரப்படி
Market-cap பிரிவு
துறை ஒதுக்கீடு
Holdings (81)
| Holding | Fund-இன் % | மதிப்பு | பங்குகள் |
|---|---|---|---|
| ICICI Bank Ltd. | 3.87% | ₹216.68 Cr | 16,39,417 |
| AU Small Finance Bank Ltd. | 3.45% | ₹193.27 Cr | 19,12,989 |
| APL Apollo Tubes Ltd. | 2.81% | ₹157.35 Cr | 7,18,473 |
| JK Cement Ltd. | 2.77% | ₹155.18 Cr | 3,05,712 |
| Navin Fluorine International Ltd. | 2.70% | ₹151.3 Cr | 1,83,508 |
| Samvardhana Motherson International Ltd. | 2.65% | ₹148.29 Cr | 90,83,296 |
| Astral Ltd. | 2.32% | ₹130.12 Cr | 9,49,512 |
| Ajanta Pharma Ltd. | 2.27% | ₹127.38 Cr | 3,51,809 |
| UNO Minda Ltd. | 2.20% | ₹123.43 Cr | 10,54,921 |
| Max Financial Services Ltd. | 2.14% | ₹120.02 Cr | 8,73,898 |
Fund விவரங்கள்
Long term capital growth and income. Investment predominantly in equity and equity related instruments as well as liquid and money market instruments.
The scheme seeks to achieve long-term growth of capital, at relatively moderate levels of risk through a diversified research based investment in Large & Midcap companies.
Exit load of 1%, if redeemed within 90 days.